So, why are companies allowed to lie and mislead users trying to purchase CBD products? This a result of the industry lacking formal regulation. This is very controversial because it opens the doors for big pharmaceutical companies and lobbyists to get away with practices that may prevent CBD from becoming easily accessible to those who need it. Hopefully, legislation like the 2018 Farm Bill will help establish competitive practices in the industry that will benefit the consumer in the long run.
In 2017, state Governor Scott Walker signed and passed the 2017 Wisconsin Act 100. This law is described as a “pilot program to study growth, cultivation, and marketing of industrial hemp.” It allows the cultivation of “only industrial hemp of the species Cannabis sativa, with THC concentration of Non-Detectable.” Republican Representative Jesse Kremer sponsored the bill. He tweeted, “signing the bill will make Wisconsin a national and global leader in hemp production.” Wisconsin is joining over 30 other states across the country that are taking advantage of this new cash crop.
CBD in Wisconsin is available for purchase prescription free both in stores and online. Online shops such as Green Roads usually have a wider selection of products ranging from their CBD oils and CBD Daily Doses to their CBD Bundles like the Sweet Tooth Box. With their wide variety of products available, every customer is sure to find what they are looking for.
Tinctures – Typically tinctures are small glass or plastic “dropper” bottles that have cannabidiol oil mixed with a preserving solution such as alcohol. Tinctures were very a very common way to ingest botanical oils prior to the industrial revolution and are experiencing a resurgence in popularity as more people are looking for natural remedies. Tinctures with droppers allow you to put a few drops in your tea, under your tongue, or to bake the oil directly into your food.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).